BioLargo’s 3rd Annual Technical Symposium Showcases its Advanced Oxidation System (AOS) and First Commercial Validation Trials Performance Results
Westminster, CA , Aug. 22, 2017 (GLOBE NEWSWIRE) -- BioLargo, Inc., (OTCQB: BLGO; www.biolargo.com), a sustainable science and technology company that delivers practical solutions for clean water, clean air and advanced wound care, announced in a blog post yesterday highlights from its 3rd annual technical symposium held at the Snow Valley Conference Center in Edmonton Alberta. The blog post, found here, included highlights regarding the successful tests conducted by a leading water engineering firm of BioLargo’s AOS system on industry-provided water, potential scalable designs of the AOS system to handle increased water flow in commercial settings, and a solar powered “AOS Mini” demonstrating the low power and flexibility of the AOS system in a design that could potentially provide clean water to extremely water-scarce or disaster-prone areas.
The company promises further updates and developments of its AOS and technical achievements in future blog posts.
About BioLargo, Inc.
BioLargo, Inc. is a sustainable science and technology company that makes life better by delivering award-winning products for clean water, clean air and advanced wound care. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases its emerging technology, the Advanced Oxidation System “AOS”, an award-winning product, having been awarded more than 35 research grants and counting, specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo's subsidiary Odor-No-More Inc., features sustainable odor elimination products including its CupriDyne Clean (www.CupriDyne.com) Industrial Odor Eliminator, a product currently serving the leading solid waste handling and wastewater treatment companies as well as any industry that must contend with malodors, VOC’s or similar air quality related problems. Its personal care products are finding adoption through white labeling or early market entry in the pet, equine, military supply and consumer markets, and include the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management featuring effective and gentle solutions for chronic infected wounds and other uses to promote infection control. BioLargo also owns a 50% interest in the Isan System, a fully automated iodine dosing system being commercialized under a license to Clarion Water, Inc.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
Source: Uptick Newswire
CONTACT: Contact: Company Contact Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2
News Provided by GlobeNewswire
© 2017 GlobeNewswire, Inc. All Rights Reserved